Schedule 13D ownership disclosure
PHASEBIO PHARMACEUTICALS INC
Security class unavailable · CUSIP: 717224109
Event date: 2018-10-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-18-322513
- Form type
- SC 13D
- Filer
- Hatteras Venture Advisors III, LLC
- CIK
- CIK 1674177
- Filed
- Nov 08, 2018
- Reporting period
- Oct 22, 2018
- Description
- Schedule 13D beneficial ownership